Suzhou Fushilai Pharmaceutical Co. Ltd. Financial Flexibility Index
Suzhou Fushilai Pharmaceutical Co. Ltd. financial flexibility index. Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) has a Financial Flexibility Index of 0.76x as of December 2024. Free cash flow of CN¥152.38 Million (operating CF CN¥47.07 Million minus capex CN¥105.31 Million) represents 1% of total liabilities (CN¥200.84 Million). Explore 301258 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Suzhou Fushilai Pharmaceutical Co. Ltd. (2019–2024)
Financial flexibility index of Suzhou Fushilai Pharmaceutical Co. Ltd. from 2019 to 2024. Historical Financial Flexibility Index trend for Suzhou Fushilai Pharmaceutical Co. Ltd. across 6 annual periods. Check Suzhou Fushilai Pharmaceutical Co. Ltd. total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Suzhou Fushilai Pharmaceutical Co. Ltd. Financial Flexibility Index by Year (2019–2024)
Suzhou Fushilai Pharmaceutical Co. Ltd. financial flexibility index by year from 2019 to 2024. Year-by-year free cash flow to debt coverage for Suzhou Fushilai Pharmaceutical Co. Ltd.. For the full cash flow conversion analysis, see cash flow conversion of Suzhou Fushilai Pharmaceutical Co. Ltd..
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.76x | CN¥152.38 Million | CN¥47.07 Million | CN¥200.84 Million | ▼ -5.2% |
| 2023 | 0.80x | CN¥136.39 Million | CN¥94.77 Million | CN¥170.45 Million | ▼ -15.8% |
| 2022 | 0.95x | CN¥201.30 Million | CN¥151.19 Million | CN¥211.75 Million | ▼ -22.9% |
| 2021 | 1.23x | CN¥280.48 Million | CN¥199.73 Million | CN¥227.47 Million | ▼ -12.2% |
| 2020 | 1.40x | CN¥232.54 Million | CN¥166.85 Million | CN¥165.61 Million | ▲ +7.4% |
| 2019 | 1.31x | CN¥221.48 Million | CN¥150.55 Million | CN¥169.48 Million | — |